MRES (Institute of Biomedical Research) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2010)


What is Institute of Biomedical Research LT-Debt-to-Total-Asset?

Institute of Biomedical Research MRES -14.62% LT-Debt-to-Total-Asset is 0.00 as of Dec. 2010.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Institute of Biomedical Research's long-term debt to total assests ratio for the quarter that ended in Dec. 2010 was 0.00.

Institute of Biomedical Research's long-term debt to total assets ratio stayed the same from Dec. 2009 (0.00) to Dec. 2010 (0.00).

Institute of Biomedical Research  (OTCPK:MRES) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Institute of Biomedical Research LT-Debt-to-Total-Asset Related Terms

Institute of Biomedical Research LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research LT-Debt-to-Total-Asset Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research LT-Debt-to-Total-Asset Calculation

Institute of Biomedical Research's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2010 is calculated as

LT Debt to Total Assets (A: Mar. 2010 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2010 )/Total Assets (A: Mar. 2010 )
=0/0.076
=

Institute of Biomedical Research's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2010 is calculated as

LT Debt to Total Assets (Q: Dec. 2010 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2010 )/Total Assets (Q: Dec. 2010 )
=0/0.655
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Institute of Biomedical Research (MRES) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2010. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's LT-Debt-to-Total-Asset too high?
Institute of Biomedical Research's current LT-Debt-to-Total-Asset is 0.00.
How does Institute of Biomedical Research's LT-Debt-to-Total-Asset compare to HSTC and NTRR?
Institute of Biomedical Research's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.